Menu

Blog

Page 7873

Apr 14, 2020

Geneticists zeroing in on genes affecting life span

Posted by in categories: biotech/medical, genetics, life extension

“We were very pleased to find out that even though life span is a very complicated trait caused by variation on a large number of loci, which is true for most complex traits, the number of loci that are in common is a totally finite number. So, we can imagine going on to the next stage and investigating one gene at a time and in combination,” Mackay said.


Scientists believe about 25 percent of the differences in human life span is determined by genetics—with the rest determined by environmental and lifestyle factors. But they don’t yet know all the genes that contribute to a long life.

A study published March 5, 2020, in PLOS Biology quantified variation in life span in the fruit fly genome, providing valuable insights for preserving health in elderly humans—an ever-increasing segment of the population. The paper titled “Context-dependent genetic architecture of Drosophila life span” is the culmination of a decade of research by Clemson University geneticists Trudy Mackay and Robert Anholt.

Continue reading “Geneticists zeroing in on genes affecting life span” »

Apr 14, 2020

Reconfigurable magnonics heats up

Posted by in category: futurism

Circa 2015


Coupling electromagnetic waves to mechanical waves has led to a remarkable miniaturization of wireless communication technologies. Now, spin waves could provide us with technologies that are small and reprogrammable.

Apr 14, 2020

CRISPR has success in treating mice with type 1 diabetes

Posted by in categories: bioengineering, biotech/medical, genetics

Circa 2017


Insulin-producing cells have been restored in mouse models of type 1 diabetes using a new genetic engineering technique.

American scientists adapted the gene editing technology known as CRISPR (clustered, regularly interspaced, short palindromic repeat) to successfully treat mouse models of type 1 diabetes, kidney disease and muscular dystrophy.

Continue reading “CRISPR has success in treating mice with type 1 diabetes” »

Apr 14, 2020

CRISPR-Cas9 successfully reverses type 2 diabetes in mice

Posted by in categories: biotech/medical, genetics

Circa 2019


Researchers at Hanyang University, South Korea, have used the gene-editing technology CRISPR-Cas9 to treat obesity and type 2 diabetes in mice, a development that could eventually benefit humans. The therapy specifically reduced fat tissue and reversed obesity-related metabolic disease in the animals.

Apr 14, 2020

Physicists to improve plasma fusion mirror devices with $5 million grant

Posted by in categories: nuclear energy, particle physics

Fusion research began in earnest in the 1960s, when scientists developed mirror machines. These linear tubes have pinched magnetic field lines on either end that act like mirrors, reflecting the charged plasma particles inward and retaining them and their heat in the machine. American researchers halted mirror research three decades ago, mainly due to an inability to contain the plasma.

WHAM will essentially take the team’s research back to the mirror machine days, but with significant upgrades.

“We hope to go well beyond what was done in the mirror program because we have access to very-high-field superconducting magnets like those being built by our partners for toroidal (donut-shaped) plasmas,” Forest says. “These magnets and heating systems simply weren’t available 20 years ago. It’s a new look at an older concept using new technology.”

Apr 14, 2020

North Korea fires barrage of missiles from ground and air

Posted by in categories: biotech/medical, existential risks, military

SEOUL, South Korea (AP) — A barrage of North Korean missiles fired from both the ground and fighter jets splashed down on the waters off the country’s east coast on Tuesday, South Korea’s military said, a show of force on the eve of a key state anniversary in the North and parliamentary elections in the rival South.

The back-to-back launches were the latest in a series of weapons tests that North Korea has conducted in recent weeks amid stalled nuclear talks and outside worries about a possible coronavirus outbreak in the country.

North Korean troops based in the eastern coastal city of Munchon first launched several projectiles — presumed to be cruise missiles — on Tuesday morning, South Korea’s Joint Chiefs of Staff said in a statement.

Apr 14, 2020

Humming greatly increases nasal nitric oxide

Posted by in category: biotech/medical

The paranasal sinuses are major producers of nitric oxide (NO). We hypothesized that oscillating airflow produced by humming would enhance sinus ventilation and thereby increase nasal NO levels. Ten healthy subjects took part in the study. Nasal NO was measured with a chemiluminescence technique during humming and quiet single-breath exhalations at a fixed flow rate. NO increased 15-fold during humming compared with quiet exhalation. In a two-compartment model of the nose and sinus, oscillating airflow caused a dramatic increase in gas exchange between the cavities. Obstruction of the sinus ostium is a central event in the pathogenesis of sinusitis. Nasal NO measurements during humming may be a useful noninvasive test of sinus NO production and ostial patency. In addition, any therapeutic effects of the improved sinus ventilation caused by humming should be investigated.

Apr 14, 2020

This Guy Says He Solved the Most Controversial Open Problem in Math

Posted by in category: mathematics

Has one of the major outstanding problems in number theory finally been solved? Or is the 600-page proof missing a key piece? The verdict isn’t in yet, but the proof, at least, will finally appear in a peer-reviewed journal.

However, there’s just one catch: the mathematician himself, Shinichi Mochizuki, is one of the journal’s seniormost editors.

Apr 14, 2020

NanoViricides, Inc. Progress on COVID-19 Drug Encouraging

Posted by in categories: biotech/medical, nanotechnology

The company’s update on its development of COVID-19 drug candidate is promising.

Vancouver, British Columbia—(Newsfile Corp. — March 31, 2020) — NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) is a nano-biopharmaceutical Company at the development stage, with proprietary and patented drug development work focused on viral diseases. The Company’s research involves the use of a unique nanomedicine technology called nanoviricides — agents designed to “fool” a virus into attaching to an antiviral nanomachine, in the same way that the virus normally attaches to the receptors on a cell surface, but for the purpose of its neutralization and destruction. NanoViricides was highlighted by SmallCapsDaily for providing an update on its progress to develop a drug that can treat COVID-19, the coronaviral pneumonia disease which is caused by the SARS-CoV-2 virus, aka, 2019-nCoV, also known as the Wuhan coronavirus.

Apr 14, 2020

DARPA has a crappy new idea to help soldiers

Posted by in category: futurism

When you’re deployed to Iraq and your stomach starts to gak, diarrhea.